Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Weighing risks and benefits of liraglutide--the FDA's review of a new antidiabetic therapy.

× No keyword cloud information.

74 in total

1. What's fueling the biotech engine-2009-2010.

Authors: Saurabh Aggarwal
Journal: Nat Biotechnol Date: 2010-11 Impact factor: 54.908

Review 2. Insulin therapy and cancer risk in diabetes mellitus.

Authors: Julia Platts
Journal: Clin Med (Lond) Date: 2010-10 Impact factor: 2.659

3. Optimizing the Care of Patients With Type 2 Diabetes Using Incretin-Based Therapy: Focus on GLP-1 Receptor Agonists.

Authors: Mansur Shomali
Journal: Clin Diabetes Date: 2014-01

Review 4. Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.

Authors: Chris de Graaf; Dan Donnelly; Denise Wootten; Jesper Lau; Patrick M Sexton; Laurence J Miller; Jung-Mo Ahn; Jiayu Liao; Madeleine M Fletcher; Dehua Yang; Alastair J H Brown; Caihong Zhou; Jiejie Deng; Ming-Wei Wang
Journal: Pharmacol Rev Date: 2016-10 Impact factor: 25.468

Review 5. Today's challenges in pharmacovigilance: what can we learn from epoetins?

Authors: Hans C Ebbers; Aukje K Mantel-Teeuwisse; Ellen H M Moors; Huub Schellekens; Hubert G Leufkens
Journal: Drug Saf Date: 2011-04-01 Impact factor: 5.606

6. Incretin-based therapy and pancreatitis: accumulating evidence and unresolved questions.

Authors: Yoshifumi Saisho
Journal: Ann Transl Med Date: 2018-04

7. Effects of liraglutide on left ventricular function in patients with non-ST-segment elevation myocardial infarction.

Authors: Wei-Ren Chen; Xue-Qin Shen; Ying Zhang; Yun-Dai Chen; Shun-Ying Hu; Geng Qian; Jing Wang; Jun-Jie Yang; Zhi-Feng Wang; Feng Tian
Journal: Endocrine Date: 2015-11-16 Impact factor: 3.633

8. Selecting GLP-1 agonists in the management of type 2 diabetes: differential pharmacology and therapeutic benefits of liraglutide and exenatide.

Authors: Jonathan Pinkney; Thomas Fox; Lakshminarayan Ranganath
Journal: Ther Clin Risk Manag Date: 2010-09-07 Impact factor: 2.423

9. Acute pancreatitis in type 2 diabetes treated with exenatide or sitagliptin: a retrospective observational pharmacy claims analysis.

Authors: Rajesh Garg; William Chen; Merri Pendergrass
Journal: Diabetes Care Date: 2010-08-03 Impact factor: 17.152

Review 10. Thyroid safety in patients treated with liraglutide.

Authors: M Gallo
Journal: J Endocrinol Invest Date: 2013-02 Impact factor: 4.256